HIV gp120 in the Lungs of Antiretroviral Therapy-treated Individuals Impairs Alveolar Macrophage Responses to Pneumococci.

MLA

Collini, Paul J., et al. “HIV Gp120 in the Lungs of Antiretroviral Therapy-Treated Individuals Impairs Alveolar Macrophage Responses to Pneumococci.” American Journal of Respiratory and Critical Care Medicine, vol. 197, no. 12, June 2018, pp. 1604–15. EBSCOhost, https://doi.org/10.1164/rccm.201708-1755OC.

APA

Collini, P. J., Bewley, M. A., Mohasin, M., Marriott, H. M., Miller, R. F., Geretti, A.-M., Beloukas, A., Papadimitropoulos, A., Read, R. C., Noursadeghi, M., & Dockrell, D. H. (2018). HIV gp120 in the Lungs of Antiretroviral Therapy-treated Individuals Impairs Alveolar Macrophage Responses to Pneumococci. American Journal of Respiratory and Critical Care Medicine, 197(12), 1604–1615. https://doi.org/10.1164/rccm.201708-1755OC

Chicago

Collini, Paul J, Martin A Bewley, Mohamed Mohasin, Helen M Marriott, Robert F Miller, Anna-Maria Geretti, Apostolos Beloukas, et al. 2018. “HIV Gp120 in the Lungs of Antiretroviral Therapy-Treated Individuals Impairs Alveolar Macrophage Responses to Pneumococci.” American Journal of Respiratory and Critical Care Medicine 197 (12): 1604–15. doi:10.1164/rccm.201708-1755OC.